Dr. Bianca Avramovitch is Senior Director in the R&D of Teva Pharmaceuticals, filling a number of positions: Global Analytical R&D Forum Leader, Head of Analytical Technologies Unit (ATU) of the Generic R&D IL, Global AQbD Leader and Global ELN (Electronic Notebooks) Platform Business Owner.
In her global Teva R&D positions, Bianca provides leadership for highly skilled multi-disciplinary local and global teams, managing cutting edge technologies and computerized based research and development across sites and cultures.
Bianca holds a Ph. D. in Physical Organic Chemistry from the Hebrew University of Jerusalem, Israel. Following her post-doctoral studies at National Institutes of Health in US on histamine receptors, Bianca joined Teva and for the last 25 years she became an expert in a number of fields, developing a diversity of drug products: tablets, capsules, suspensions, sterile and injectable products, nasals, creams, and more. Analytical research and development areas which are up to today under her immediate responsibility are: solid state characterization aspects as polymorphism in Drug Substances and Products, particle size distribution by techniques such as laser diffraction and imaging, various physical properties characterization and measurement, Impurities mapping and characterization (identification by GC-MS and LC-MS/MS, by Capillary Electrophoresis).
Bianca is also holding the expert position in council of experts of the USP (United States Pharmacopoeia) being elected for a second cycle of 5 years. She is a member of the organizing committee of ISRANALYTICA. Bianca held various leadership functions in non-profit organizations and teaching environments, while lately she earned the "Making your family proud" value award of Teva for designing the Teva lab kit, the portable lab for parents to present the magic of chemistry in their children classrooms.